Huwel Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 2.05 Cr
- Paid Up Capital ₹ 5.99 M
- Company Age 10 Year, 13 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 24.75 Cr
- Revenue Growth -77.78%
- Profit Growth -96.75%
- Ebitda -106.70%
- Net Worth 6.08%
- Total Assets 6.60%
About Huwel Lifesciences
Huwel Lifesciences Private Limited (HLPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 10 February 2015 and has a history of Ten years. Its registered office is in Medak, Telangana, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.05 Cr and a paid-up capital of Rs 5.99 M.
The company currently has active open charges totaling ₹24.75 Cr.
Shesheer Munpally and Rachana Tripathi serve as directors at the Company.
Company Details
- Location
Medak, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U33111TG2015PTC097596
- Company No.
097596
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Feb 2015
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
What products or services does Huwel Lifesciences Private Limited offer?
Huwel Lifesciences Private Limited offers a wide range of products and services, including Diagnostic Imaging & Pathology Labs, Medical Test Services, Medical Laboratory Instruments, Corona Test Kit, Rapid Test Kit.
Who are the key members and board of directors at Huwel Lifesciences?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shesheer Munpally  | Director | 16-May-2018 | Current |
| Rachana Tripathi | Director | 01-Sep-2017 | Current |
Financial Performance of Huwel Lifesciences.
Huwel Lifesciences Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 77.78% decrease. The company also saw a substantial fall in profitability, with a 96.75% decrease in profit. The company's net worth moved up by a moderate rise of 6.08%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Huwel Lifesciences?
In 2022, Huwel Lifesciences had a promoter holding of 94.89% and a public holding of 5.11%. The company had 2 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Bioras Pharma Private LimitedShesheer Munpally and Rachana Tripathi are mutual person
- Hlss Manufacturing Private Limited
Shesheer Munpally and Rachana Tripathi are mutual person
- Sirf Bio Private Limited
Shesheer Munpally is a mutual person
- Hlabs Private Limited
Shesheer Munpally and Rachana Tripathi are mutual person
- Bhubaneswar City Knowledge Innovation Cluster Foundation
Shesheer Munpally is a mutual person
- Varam Medtech Foundation
Shesheer Munpally is a mutual person
Charges (Loans)
₹24.75 Cr
₹0
Charges Breakdown by Lending Institutions
- Others : 16.25 Cr
- Sidbi : 5.00 Cr
- Axis Bank Limited : 3.50 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 11 Aug 2023 | Sidbi | ₹2.50 Cr | Open |
| 29 Mar 2023 | Others | ₹15.75 Cr | Open |
| 30 Sep 2021 | Sidbi | ₹2.00 Cr | Open |
| 30 Apr 2021 | Axis Bank Limited | ₹3.50 Cr | Open |
| 12 May 2020 | Sidbi | ₹5.00 M | Open |
How Many Employees Work at Huwel Lifesciences?
Unlock and access historical data on people associated with Huwel Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Huwel Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Huwel Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
